BioMatNet Logo
[BioMatNet Database - FP5 Quality of Life Programme] QLK5-2002-01330
Biomedical Textiles from Dibutyrylchitin and Chitin - CHITOMED
Contacts
Further Information



To find similar Items, click on a keyword below:
Biological Conversion : Biopolymers/Gums : Quality of Life - 5.2 Non-Food Development : Textiles/Fabrics/Geomembranes



Contract No: QLK5-2002-01330
Project Type: RS (Research and Technological Development Project)
Start Date: 01-01-2003
Duration: 36 Months
Total Cost: 1,978,388 EUR
EC Contribution: 1,364,924 EUR
Scientific Officer: Ciaran MANGAN

Abstract

There is a lack of innovative biomaterials that aid in regeneration of wound tissue on the European market. This project aims to design and develop optimal textile forms for medical applications made from dibutyrylchitin (DBC) and chitin derived from fishery by-products. Recently a method for the synthesis of DBC has been developed. DBC is easily soluble in common recyclable solvents and has both film and fibre forming properties. Chitin can be produced as regenerated chitin (RC). These products are assumed to have wound healing properties. This opens the way for the development of novel functional biomaterials made from DBC and RC. Technologies for the production of fibres, yarns, non-wovens and knitted fabrics will be developed. The textiles will be designed to requirements and characterised on mechanical, physico-chemical and biochemical-medical (in vitro and in vivo) properties. Applications for approval as medical products will be initiated.

Objectives

Chemical and textile companies will make joint efforts with universities to develop the production of DBC, spinning technology of DBC and mixed DBC/cellulose fibres and yarns, production of DBC textiles, regenerated chitin in similar manufactured products. An industrial company active in the medical field will co-operate with laboratories/hospitals, where the bioactivity and biocompatibility of these novel biomaterials can be assessed. The project will generate novel biomaterials and medical items, that accelerate the wound healing with no scar formation or undesirable effects, are easy to handle and could be prepared as self-adhering dressings. This kind of dressing should reduce the pain and suffering of patients. The project is oriented and targeted to improve the competitiveness of European industry and enhancing the quality of life of the EU citizen through the sustainable production and rational utilisation of natural resources with the special emphasis on new technologies.

Description of the work

The work plan is structured in such way as to make the research results really applicable commercially. The core of the project is the chemistry, textile technology, biochemistry and investigation of biological/medical properties of obtained forms of biomaterials. Six industrial companies and three universities, in five countries will carry out this work. The work plan is divided in work packages as follows:

  • Production technology and development of dibutyrylchitin (DBC)
  • Production technology development of fibres and multi-filament yarns from DBC
  • Processing of DBC fibres into high performance textiles.
  • Regeneration of DBC textile materials into pure chitin (RC) textile materials.
  • Assessment of the safety-related biochemical /biological and medical properties of DBC and fibres and textiles.
  • Design and development of opilmal forms of DBC and RC biomaterials.
  • Technical documentation for commercialisation of the production of the new generation of biomaterials from DBC and/or RC.

Management, exploitation of results and Technology Implementation Plan

This work will start with the selection of commercial chitins (from seafood waste) according to the criteria of purity, constant quality reliability supply and suitability for transformation into dubutyrylchitin. The latter will be synthesized from butyric anhydride and chitin, at room temperature, and spun into fibres and yarns. The fibres and yarns will be used to manufacture non-wovens and knitted biomaterials. They will be characterized on biochemical/medical properties in terms of biocompatibility.





Contacts

Coordinator

Participant

© Copyright 2006    Policy Statements    
Updated by CPL Press: 03/07/2007 - biomatnet@biomatnet.org

 


with Google

News

Global News ...

View All News Items...

Events

Events Diary ...

 
BioMatNet Database Sixth Framework Programme (FP6) Research Home Page